Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.

Khoury JD, Medeiros LJ, Manning JT, Sulak LE, Bueso-Ramos C, Jones D.

Cancer. 2002 May 1;94(9):2401-8.

2.
3.

[Hematodermic CD4/CD56 neoplasm].

Petrella T, Wechsler J, Courville P, de Muret A, Bosq J, Déchelotte P, Feuillard J, Durlach A, Vergier B.

Ann Pathol. 2004 Jun;24(3):241-55; quiz 227. Review. French.

PMID:
15480259
4.

CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.

Herling M, Jones D.

Am J Clin Pathol. 2007 May;127(5):687-700. Review.

PMID:
17439829
5.

A cutaneous agranular CD2- CD4+ CD56+ "lymphoma": report of two cases and review of the literature.

Kameoka J, Ichinohasama R, Tanaka M, Miura I, Tomiya Y, Takahashi S, Yamada M, Ishikawa I, Kadowaki I, Sasaki O, Kimura J, Meguro K, Ooya K, Ito S.

Am J Clin Pathol. 1998 Oct;110(4):478-88. Review.

PMID:
9763034
6.

CD56-positive (nasal-type T/NK cell) lymphoma arising on the skin. Report of two cases and review of the literature.

Ansai S, Maeda K, Yamakawa M, Matsuda M, Saitoh S, Suwa S, Saitoh H, Ohtsuka M, Iwatsuki K.

J Cutan Pathol. 1997 Sep;24(8):468-76. Review.

PMID:
9331892
7.

CD56+ lymphoma with skin involvement: clinicopathologic features and classification.

Gniadecki R, Rossen K, Ralfkier E, Thomsen K, Skovgaard GL, Jønsson V.

Arch Dermatol. 2004 Apr;140(4):427-36. Review.

PMID:
15096371
8.

CD2- CD4+ CD56+ hematodermic/hematolymphoid malignancy.

Kato N, Yasukawa K, Kimura K, Sugawara H, Aoyagi S, Mishina T, Nakata T.

J Am Acad Dermatol. 2001 Feb;44(2):231-8. Review.

PMID:
11174380
9.

Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.

Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M, Meijer CJ, Courville P, Joly P, Grange F, De Muret A, Machet L, Dompmartin A, Bosq J, Durlach A, Bernard P, Dalac S, Dechelotte P, D'Incan M, Wechsler J, Teitell MA.

Am J Clin Pathol. 2005 May;123(5):662-75. Review.

PMID:
15981806
10.

CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor).

Shiman M, Marchione R, Ricotti C, Romanelli P, Alonso-Llamazares J.

Dermatol Online J. 2008 Nov 15;14(11):5. Review.

PMID:
19094843
11.

[Rare diagnosis of CD4+56+ leukemia from dendritic cells type DC2].

Klabusay M, Pevná M, Kissová J, Doubek M, Heidekerová M, Mayer J, Vorlícek J.

Cas Lek Cesk. 2008;147(10):511-5. Review. Czech.

PMID:
19177732
12.

Cutaneous monomorphous CD4- and CD56-positive large-cell lymphoma.

Nagatani T, Okazawa H, Kambara T, Satoh K, Tokura H, Miyazawa M, Yamada R, Baba N, Nakajima H, Yamazaki E, Kanamori H, Mohri H.

Dermatology. 2000;200(3):202-8. Review.

PMID:
10828627
13.

Pediatric acute blastic natural killer cell leukemia.

DuBois SG, Etzell JE, Matthay KK, Robbins E, Banerjee A.

Leuk Lymphoma. 2002 Apr;43(4):901-6. Review.

PMID:
12153184
14.

Blastic natural killer (NK)-cell lymphoma: report of an unusual CD4 negative case and review of the CD4 negative neoplasms with blastic features in the literature.

Argyrakos T, Rontogianni D, Karmiris T, Kapsimali V, Grigoriou E, Tsantekidou M, Naum C, Galani V, Pantelidaki C, Harhalakis N, Nikiforakis E, Kanavaros P.

Leuk Lymphoma. 2004 Oct;45(10):2127-33. Review.

PMID:
15370260
15.

Mycosis fungoides with a CD56+ immunophenotype.

Wain EM, Orchard GE, Mayou S, Atherton DJ, Misch KJ, Russell-Jones R.

J Am Acad Dermatol. 2005 Jul;53(1):158-63. Review.

PMID:
15965442
16.

Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature.

Maitra A, McKenna RW, Weinberg AG, Schneider NR, Kroft SH.

Am J Clin Pathol. 2001 Jun;115(6):868-75. Review.

PMID:
11392884
17.

Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review.

Shi Y, Wang E.

Arch Pathol Lab Med. 2014 Apr;138(4):564-9. doi: 10.5858/arpa.2013-0101-RS. Review.

PMID:
24678689
18.

Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia.

Alvarez-Larrán A, Villamor N, Hernández-Boluda JC, Ferrer A, Camós M, Campo E, López-Guillermo A.

Clin Lymphoma. 2001 Dec;2(3):178-82; discussion 183-4. Review.

PMID:
11779295
19.

Clinical utility of leukemia cell terminal transferase measurements.

McCaffrey R, Lillquist A, Sallan S, Cohen E, Osband M.

Cancer Res. 1981 Nov;41(11 Pt 2):4814-20. Review.

20.

CD4+ CD56+ hematodermic neoplasm and plasmacytoid dendritic cell tumor: case report and review of the literature.

Campbell SM, Moad JC, Sammons DL, Zirwas M.

Cutis. 2012 Jun;89(6):278-83. Review.

PMID:
22838092

Supplemental Content

Support Center